By Jackie Bryant La Jolla, California-based Artelo Biosciences, Inc. (Nasdaq: ARTL) recently announced that its Canadian subsidiary, Artelo Biosciences Corporation, is the recipient of a Mitacs Accelerate Grant that will allow the company to further its research on ART26.12, a product candidate for the treatment of anxiety, cancer, inflammation, and pain. Mitacs is a Canadian non-profit research organization. The grant […]
Read More